Christopher McMaster
6Patents
1h-index
8Co-inventors
40Inventor score
Filing activity: Dec 8, 2000 → Sep 27, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8835476B2 | Synthesis of novel antimicrobials | Emerging Cross-Sectional Technologies | 1 | Active |
| US10487082B2 | S1PR2 antagonists and uses therefor | Chemistry; Metallurgy | 1 | Active |
| US6451568B1 | Cloning of human choline ethanolaminephospho transferases synthesis of phosphatidyl choline phosphatidyle thanolamine and platelet activating factor | Chemistry; Metallurgy | 0 | Expired |
| US10858358B2 | S1PR2 antagonists and uses therefor | Chemistry; Metallurgy | 0 | Active |
| US10058543B2 | Treatment of familial exudative vitreoretinopathy through S1PR2 inhibition | Human Necessities | 0 | Active |
| US12358902B2 | 5-(2,5-bis(4-chloro-2-isopropylphenyl)thiophen-3-yl)-1H-tetrazole for the topical treatment of bacterial infections | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.